Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biostem Technologies Inc
(OP:
BSEM
)
17.30
-6.05 (-25.93%)
Streaming Delayed Price
Updated: 3:43 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
255,376
Open
22.55
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
23.36
Today's Range
16.51 - 23.25
52wk Range
2.342 - 28.26
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
July 16, 2024
Via
AB Newswire
Exposures
Product Safety
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
July 15, 2024
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Performance
YTD
+184.77%
+184.77%
1 Month
+44.17%
+44.17%
3 Month
+37.08%
+37.08%
6 Month
+78.35%
+78.35%
1 Year
+433.95%
+433.95%
More News
Read More
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
October 24, 2023
Via
ACCESSWIRE
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
October 17, 2023
Via
ACCESSWIRE
BioStem Technologies: CMS Decision a “Win For Patients”
September 29, 2023
Via
ACCESSWIRE
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
September 26, 2023
Via
ACCESSWIRE
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
September 19, 2023
Via
ACCESSWIRE
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
September 18, 2023
Via
ACCESSWIRE
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
September 11, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
January 30, 2023
Via
Benzinga
2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
January 13, 2023
Via
Benzinga
BioStem Technologies Announces Partnership with Kill Cliff FC
December 14, 2022
From
BioStem Technologies, Inc.
Via
GlobeNewswire
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022
From
BioStem Technologies, Inc.
Via
GlobeNewswire
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
November 15, 2022
From
BioStem Technologies, Inc.
Via
GlobeNewswire
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
October 26, 2022
From
BioStem Technologies, Inc.
Via
GlobeNewswire
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
October 10, 2022
From
BioStem Technologies, Inc.
Via
GlobeNewswire
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
September 22, 2022
Via
Benzinga
EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
May 16, 2022
Via
Benzinga
Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
April 22, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
